Implants News and Research

RSS

First Edition: September 2, 2011

On Kaiser Health News' blog, staff writer Julie Appleby writes: "Insurers who offer 'association health plans,' which are often sold through trade groups or other organizations of affiliated members, will face the same scrutiny of premium rate hikes as other types of insurance, federal officials said Thursday."

2 Sep 2011

FDA panel on post-approval studies of silicone breast implants

A panel of expert advisors to the FDA has been asked to look into the matter of the thousands of women who enrolled in studies designed to evaluate rare complications that might arise years after they received silicone gel breast implants.

31 Aug 2011

UHC Supply Chain helps University of Iowa Hospitals and Clinics to save $14M in 18 months

A supply chain strategy built on excellence in customer service and a partnership with UHC Supply Chain has helped UHC member University of Iowa Hospitals and Clinics initiate 35 projects that saved more than $14 million in 18 months.

30 Aug 2011

Occlutech to close 15 million Euro investment

Occlutech, a leading European developer of medical implants treating structural heart disease such as PFO, ASD and LAA today announced the closing of a 15 million Euro investment into Occlutech.

24 Aug 2011

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

IsoRay, Inc. said today that a growing number of hospitals and medical treatment centers are adopting its proprietary mesh Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) for use in conjunction with the da Vinci® Surgical System to treat early stage lung cancer patients. One of the most recent adopters is Georgia's Archbold Memorial Hospital.

23 Aug 2011

Living Cell Technologies xenoimplants first patients in Argentina trial

Living Cell Technologies Limited has implanted the first two patients taking part in a Phase II DIABECELL® clinical trial in Buenos Aires, Argentina.

22 Aug 2011

Time-release corticosteroid implant effective in treating uveitis

A team of researchers comparing the two leading treatment approaches for the eye condition uveitis, which is the fifth leading cause of blindness in the US, have found that a time-release corticosteroid implant placed surgically in the eye is similarly effective in treating the disease as anti-inflammatory corticosteroids and immunosuppressive drugs taken orally. The report was published online this week in the journal Ophthalmology.

19 Aug 2011

OrthoSensor, Stryker partner for intelligent knee surgical trial

Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor Knee Trial, designed for use with Stryker's Triathlon Knee System.

From Stryker 18 Aug 2011

Abbott initiates ABSORB BVS device clinical trial in coronary artery disease

Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.

18 Aug 2011

L3I announces new Outcome Based Partnership hybrid business model

Level 3 Inspection has announced an Outcome Based Partnership hybrid business model based on vested interest partnership and proven time-to-market savings.

12 Aug 2011

Leading dental and pharmacy organizations to raise awareness on xerostomia

Leading dental and pharmacy organizations are teaming up to promote oral health and raise public awareness of dry mouth, a side effect commonly caused by taking prescription and over-the-counter medications.

12 Aug 2011

House Research Institute's new campaign to raise funds of $65 million

House Research Institute announced today the 65 Faces Campaign to coincide with the 65th anniversary of the institute. The fundraising goal of the campaign is $65 million.

11 Aug 2011

Conference to explore new discoveries about origins, diagnosis and treatment of tinnitus

University at Buffalo research showing that a new drug that eliminated tinnitus with a single dose in animal models is among the advances that will be presented at the Fifth Tinnitus Research Initiative Conference, "The Neuroscience of Tinnitus," sponsored by UB's Center for Hearing and Deafness Aug. 19-21 in Grand Island, N.Y.

11 Aug 2011

NSF awards WSU researcher CAREER grant to develop neural implants

Neural implants have the potential to treat disorders and diseases that typically require long-term treatment, such as blindness, deafness, epilepsy, spinal cord injury, and Alzheimer's and Parkinson's. However, implantable devices have been problematic in clinical applications because of bodily reactions that limit device functioning time.

4 Aug 2011

Artimplant reports net revenue of SEK 9.7 million for January – June, 2011

Artimplant: First six months: Net revenue amounted to SEK 9.7 million.

3 Aug 2011

Tornier announces two milestone events for Simpliciti stemless shoulder system

Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced two milestone events for the Company's new SimplicitiTM stemless shoulder joint replacement system.

3 Aug 2011

Kelyniam commences commercial shipment of Custom Skull Implants

Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.

2 Aug 2011

Bioengineered spinal discs can prevent chronic back or neck pain

Every year, millions of people contend with lower back and neck discomfort. With intent to ease their pain, Cornell University engineers in Ithaca and doctors at the Weill Cornell Medical College in New York City have created a biologically based spinal implant that could someday spell relief for these countless sufferers.

2 Aug 2011

New liquid material shows promise for people with facial deformities

Biomedical engineers at Johns Hopkins have developed a new liquid material that in early experiments in rats and humans shows promise in restoring damaged soft tissue relatively safely and durably.

2 Aug 2011

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial.

27 Jul 2011